Couverture de Px Pulse

Px Pulse

Px Pulse

De : Px Pulse
Écouter gratuitement

3 mois pour 0,99 €/mois

Après 3 mois, 9.95 €/mois. Offre soumise à conditions.

À propos de ce contenu audio

Px Pulse explores vital topics confronting the field of HIV prevention research. Our monthly podcast will deepen your knowledge and help you “check the pulse” of this fast-paced field and the urgent challenges still ahead. Tune in for interviews, first-person accounts and robust discussion from advocates, researchers, policy-makers and community stakeholders as they take on critical issues facing HIV prevention research today.

AVAC.org Hygiène et vie saine Science
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Épisodes
    • S5 Ep19: Up Next: A monthly pill for PrEP?

      S5 Ep19: Up Next: A monthly pill for PrEP?
      Aug 15 2025
      The drug maker Merck recently announced its plans to start two new trials, known as the EXPrESSIVE program, testing a monthly pill for PrEP. A once-a-month PrEP pill holds great potential for the field. Even with daily pills, a monthly ring, or long acting injectables such as cabotegravir and recently FDA-approved lenacapavir, there’ll be people who can’t find what they really need for prevention.

      For advocates who follow prevention, there’s a lot to know about these trials, and powerful lessons to learn about Good Participatory Practice (GPP) and impactful involvement of stakeholders—especially community—in research. GPP has been a cornerstone of the process of design and protocol development for the EXPrESSIVE trials, and it doesn’t stop there.

      This episode features Merck Senior Principal Scientist Rebeca Plank and AVAC’s Regional Manager for Research Engagement Grace Kumwenda. They explain why a monthly pill could be so important to HIV prevention and how GPP is shaping the design and rollout of the trials.

      Afficher plus Afficher moins
      15 min
    • S5 Ep18: Critical Advocacy: How Civil Society is defending the HIV Response and Global Health

      S5 Ep18: Critical Advocacy: How Civil Society is defending the HIV Response and Global Health
      May 13 2025
      The upending of US policy by the new presidential administration has collapsed the foundation for global health and the HIV response at every level, from research to program delivery. It’s been a desperate scramble for everyone who cares the lives and wellbeing of those impacted by HIV. Wading into the chaos, all over the world are advocates who began organizing within days, even minutes—as soon as the US government federal executive orders started coming down.

      Positive change depends on fierce and effective community leadership, and pressuring powerbrokers to do the right thing.)

      Two veteran global health leaders from civil society talk about how civil society is responding. Amanda Banda is Strategic Advisor to the COMPASS Coalition and Asia Russell is Executive Director of Health Gap, and both are members of CHANGE, a coalition with more than 1,500 people, from organizations in nearly every continent, working in coordination to defend global health and the HIV response.
      https://avac.org/resource/critical-advocacy/
      Key Resources
      • Join weekly CHANGE calls, every Thursday 9 AM Washington DC | 4 PM Nairobi to get involved, send us an email for the link to join: contact.change.2025@gmail.com
      • CHANGE resources to fight back against US government HIV and global health cuts and funding freezes, visit pepfarwatch.org/pepfar-funding-freeze
      • Research Matters – Resources to Protect Research Funding
      • PxWire: May 2025
      • Despite USG Global Health Collapse, Here Are Several Data Trackers To Support Your Advocacy
      Afficher plus Afficher moins
      20 min
    • S5 Ep17: Lawsuit Wins and What’s at Stake

      S5 Ep17: Lawsuit Wins and What’s at Stake
      Apr 7 2025
      On February 10, AVAC and the Journalism Development Network came forward with Public Citizen to sue the new US presidential administration, seeking emergency relief from the funding freeze on all foreign assistance. We know the impact of the withdrawal of funds has been devastating. AVAC’s lawsuit is one of several efforts to fight back in the courts.

      AVAC’s Executive Director, Mitchell Warren and Public Citizen Litigator, Lauren Bateman explain these lawsuits and why they matter. For resources and other background go to https://avac.org/resource/lawsuit-wins-and-whats-at-stake/
      Afficher plus Afficher moins
      14 min
    Aucun commentaire pour le moment